Octavus Consulting- Evidence-Based Consulting Services.

Call us: +91 120 428 0707

Email us: bd@octavusconsulting.com

Contact Us
Contact Us

Aditya Singh

  • Home
  • Author: Aditya Singh
22
Oct
No Comments

Strategic Intelligence in Biopharma M&A: Seeing the Deal Before It Happens

When Gilead acquired Forty Seven Inc. in 2020, most observers called it quick. Those who tracked macrophage checkpoint research knew it was inevitable. That’s the power of strategic intelligence—not reacting to news, but foreseeing inevitabilities. At Octavus Consulting, we help clients move from rumor-driven scouting to pattern-based acquisition strategy. In 2025’s market—where capital discipline and […]
Continue Reading
15
Oct
, No Comments

Real-World Evidence 2.0: From Post-Market Validation to Strategic Design

In 2025, Real-World Evidence (RWE) is no longer an afterthought in regulatory filings. It’s a design principle. We recently worked with a biotech firm developing an oncology therapy struggling with limited trial enrollment and payer skepticism. Instead of waiting until post-launch to demonstrate real-world value, they embedded RWE from day one. By integrating claims and […]
Continue Reading
24
Sep
No Comments

Trending Technologies in Healthcare Data Analysis

Be it diagnosis, digitization of patient records, or monitoring patients’ vitals, technology has always worked as a driving force to influence the healthcare sector. The healthcare sector has ameliorated to new heights with interminable innovations and technological advancement. From the use of artificial intelligence in diagnosis to the advent of telemedicine, the healthcare sector and […]
Continue Reading

Categories

Subscribe Newsletter

Sign up to receive notifications about the latest news and events from us!